Managing SQL Server across hybrid and multi-cloud environments has long posed a challenge for database administrators. With data sprawled across on-premises infrastructure, cloud platforms, and edge ...

The water restrictions taking effect Monday in Raleigh are expected to last more than a month, according to a city spokesperson. City of Raleigh environmental coordinator Ed Buchan estimated that the ...

A surprising new clinical trial has revealed that metformin—a cheap, century-old drug widely used for type 2 diabetes—may help people with type 1 diabetes in an unexpected way. While researchers ...

Deal combines Cook Islands leases, international claims Aiming to produce copper, nickel, cobalt, manganese Odyssey shares up more than 85% Emmy-winner Mike Rowe major investor The move, announced on ...

Denver Board of Water Commissioners adopted a resolution approving the implementation of temporary drought pricing at a meeting Wednesday. Denver Water said that the drought pricing will apply ...

The World Anti-Doping Agency (WADA) said it is now monitoring GLP-1 use among elite athletes, including at the Winter Olympics in Italy. Being ‘monitored’ does not mean a substance is prohibited; ...

GLP-1 medications can alter bowel movements, with constipation and diarrhea being the most common side effects. These drugs slow digestion to help control appetite, which can lead to changes in stool ...

For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an opportunity and a threat to their businesses. About one in every eight U.S. adults is currently taking a ...

Something to look forward to: A resourceful team of modders has set the ambitious goal of transforming the entire Baldur's Gate 1 game into a custom campaign using the Baldur's Gate 3 engine. Powered ...

A new study suggests short-term or interrupted GLP-1 use could put stress on the cardiovascular system and undo hard-won health improvements. A new diabetes study found that three years on a GLP-1 ...

Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, approximately one in eight U.S. adults now take these medications, which also ...

Kendra Pierre-Louis: For Scientific American’s Science Quickly, I’m Kendra Pierre-Louis, in for Rachel Feltman. In early March the U.S. Food and Drug Administration sent a warning letter to Novo ...